Find Buloxibutid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 477775-14-7, Compound 21, At2 agonist c21, Buloxibutid, At2 receptor agonist c21, M 24
Molecular Formula
C23H29N3O4S2
Molecular Weight
475.6  g/mol
InChI Key
XTEOJPUYZWEXFI-UHFFFAOYSA-N
FDA UNII
RC2V4W0EYC

Buloxibutid
1 2D Structure

Buloxibutid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate
2.1.2 InChI
InChI=1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27)
2.1.3 InChI Key
XTEOJPUYZWEXFI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3
2.2 Other Identifiers
2.2.1 UNII
RC2V4W0EYC
2.3 Synonyms
2.3.1 MeSH Synonyms

1. C-21

2. C-21 Sodium

3. C21

4. C21 Sodium

5. Compound 21

6. Compound 21 Sodium

2.3.2 Depositor-Supplied Synonyms

1. 477775-14-7

2. Compound 21

3. At2 Agonist C21

4. Buloxibutid

5. At2 Receptor Agonist C21

6. M 24

7. C-21

8. Rc2v4w0eyc

9. Chembl189568

10. T2 Agonist Compound 21

11. Compound 21 [pmid: 22802221]

12. M-24

13. Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate

14. Butyl 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-ylsulfonylcarbamate

15. Butyl ((3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonyl)carbamate

16. N-[[3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]carbamic Acid Butyl Ester

17. Butyl [3-[4-[(1h-imidazol-1-yl)methyl]phenyl]-5-isobutylthiophen-2-yl]sulfonylcarbamate

18. Carbamic Acid, ((3-(4-(1h-imidazol-1-ylmethyl)phenyl)-5-(2-methylpropyl)-2-thienyl)sulfonyl)-, Butyl Ester

19. Carbamic Acid, [[3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, Butyl Ester

20. Buloxibutid [inn]

21. 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] Sodium Salt

22. Unii-rc2v4w0eyc

23. Schembl557591

24. Gtpl6918

25. C 21 [who-dd]

26. Xteojpuyzwexfi-uhfffaoysa-n

27. Bcp30872

28. Cua77514

29. Bdbm50156173

30. Akos030231077

31. At18254

32. Sb18730

33. Ncgc00386668-01

34. M024/c21

35. Ms-28827

36. Ds-017243

37. Hy-100113

38. Cs-0018094

39. M-024

40. M 24;m-24;m24;c-21

41. Q27076423

42. N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide

43. (1-((2''-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1h-imidazol-5-yl)methanol

44. Butyl [3-{4-[(1h-imidazol-1-yl)methyl]phenyl}-5-(2-methylpropyl)thiophene-2-sulfonyl]carbamate

45. Butyl N-{3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-ylsulfonyl}carbamate

46. Carbamic Acid, [[3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfon Yl]-, Butyl Ester

47. Carbamic Acid,[[3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, Butyl Ester

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 475.6 g/mol
Molecular Formula C23H29N3O4S2
XLogP35.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count11
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area127
Heavy Atom Count32
Formal Charge0
Complexity690
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents

Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Looking for 477775-14-7 / Buloxibutid API manufacturers, exporters & distributors?

Buloxibutid manufacturers, exporters & distributors 1

30

PharmaCompass offers a list of Buloxibutid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Buloxibutid manufacturer or Buloxibutid supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Buloxibutid manufacturer or Buloxibutid supplier.

PharmaCompass also assists you with knowing the Buloxibutid API Price utilized in the formulation of products. Buloxibutid API Price is not always fixed or binding as the Buloxibutid Price is obtained through a variety of data sources. The Buloxibutid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Buloxibutid

Synonyms

477775-14-7, Compound 21, At2 agonist c21, At2 receptor agonist c21, M 24, C-21

Cas Number

477775-14-7

Unique Ingredient Identifier (UNII)

RC2V4W0EYC

Buloxibutid Manufacturers

A Buloxibutid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Buloxibutid, including repackagers and relabelers. The FDA regulates Buloxibutid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Buloxibutid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Buloxibutid Suppliers

A Buloxibutid supplier is an individual or a company that provides Buloxibutid active pharmaceutical ingredient (API) or Buloxibutid finished formulations upon request. The Buloxibutid suppliers may include Buloxibutid API manufacturers, exporters, distributors and traders.

Buloxibutid GMP

Buloxibutid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Buloxibutid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Buloxibutid GMP manufacturer or Buloxibutid GMP API supplier for your needs.

Buloxibutid CoA

A Buloxibutid CoA (Certificate of Analysis) is a formal document that attests to Buloxibutid's compliance with Buloxibutid specifications and serves as a tool for batch-level quality control.

Buloxibutid CoA mostly includes findings from lab analyses of a specific batch. For each Buloxibutid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Buloxibutid may be tested according to a variety of international standards, such as European Pharmacopoeia (Buloxibutid EP), Buloxibutid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Buloxibutid USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty